Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New anesthesia drug may offer safer surgery for endometrial cancer patients

NCT ID NCT07372209

First seen Jan 31, 2026 · Last updated May 25, 2026 · Updated 12 times

Summary

This study looked at whether a drug called oliceridine is safe and effective for putting patients to sleep during gynecologic laparoscopic surgery for endometrial cancer. Researchers compared it to another drug, sufentanil, by checking changes in blood pressure and heart rate. The study involved 120 adults aged 18-65 who were scheduled for surgery. The goal was to find a better way to manage anesthesia and reduce side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTUBATION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Tangshan Maternal and Child Health Hospital

    Tangshan, Hebei, 063000, China

Conditions

Explore the condition pages connected to this study.